Refine
Has Fulltext
- yes (101)
Is part of the Bibliography
- yes (101)
Year of publication
Document Type
- Journal article (101) (remove)
Language
- English (101) (remove)
Keywords
- glycine receptor (6)
- neurons (5)
- spinal muscular atrophy (5)
- BDNF (4)
- hyperekplexia (4)
- motoneurons (3)
- neurology (3)
- neuromuscular junction (3)
- startle disease (3)
- synaptic vesicles (3)
- Cys-loop receptor (2)
- Neurotrophic factors (2)
- RNA (2)
- TrkB (2)
- amyotrophic lateral sclerosis (2)
- autophagy (2)
- axons (2)
- binding (2)
- ciliary neurotrophic factor (2)
- cortical neurons (2)
- drosophila melanogaster (2)
- growth cone (2)
- hippocampus (2)
- hybridomas (2)
- immunoprecipitation (2)
- melt electrowriting (2)
- neurofascin (2)
- neuropathic pain (2)
- pain (2)
- receptor (2)
- spinal cord (2)
- synaptic inhibition (2)
- synaptic plasticity (2)
- 2-pore potassium channel (1)
- 3D cell culture (1)
- 3D cell cultures (1)
- 3D electrophysiology (1)
- 3D microfiber (1)
- 3D model systems (1)
- 3D neuronal networks (1)
- 3D tumor model (1)
- Aging (1)
- Alpha-synuclein oligomers (1)
- Alzheimer disease (1)
- Alzheimer's disease (1)
- Alzheimers disease (1)
- Alzheimer’s disease (1)
- Amyloid-beta oligomers; (1)
- Amyotrophic-lateral-sclerosis (1)
- Asc-1 transporter (1)
- Associative learning (1)
- Astrocytes ; Schwann cells ; Interferon-gamma ; Fibroblast growth factor ; Cyclic AMP (1)
- Autism spectrum disorders (1)
- Axon degeneration (1)
- Axon growth (1)
- Axonal transport (1)
- BDNF stimulation (1)
- BSTA (1)
- Brain (1)
- C. elegans (1)
- C9orf72 (1)
- COVID-19 (1)
- Ca\(^{2+}\)-Imaging (1)
- Ca\(_{v}\)2.2 (1)
- Cav2.2 (1)
- Cells (1)
- Cellular prion protein (1)
- Central nervous system (1)
- DAPI staining (1)
- DNA repeat expansion (1)
- DRD1 (1)
- Dentate granule cells (1)
- Down syndrome (1)
- Drosophilia (1)
- Exercise (1)
- F-actin (1)
- Facial Nerve Transection (1)
- Familial Alzheimers-disease (1)
- Fear conditioning (1)
- Fibroblast Growth Factor (1)
- GABA-A receptor (1)
- GABA\(_{A}\) (1)
- GABA\(_{A}\) receptor (1)
- GPCR (1)
- Glutamatergic synapses (1)
- GlyR receptors (1)
- GlyRs (1)
- Guillain-Barre-Syndrome (1)
- Hippocampus (1)
- IGF1 (1)
- IgG4 (1)
- Ighmbp2 (1)
- Immunopanning (1)
- Inhibitory glycine receptor (1)
- Insulinlike Growth Factor (1)
- Intermediate filaments (1)
- JNK (1)
- Kenyon cells (1)
- Lacking neurofilaments (1)
- Learning and memory (1)
- Lysosomal storage disease (1)
- MAP1B (1)
- MOC fibers (1)
- Microtubules (1)
- Missense mutation (1)
- Molecular neuroscience (1)
- Motoneuron disease (1)
- Motor behaviour (1)
- Motor neuron disease; Ciliary neurotrophic factor; Brain-derived neurotrophic factor; Animal models; Neurotrophic factors (1)
- Mouse model (1)
- Mus spretus (1)
- NMDAR (1)
- NMJ–neuromuscular junction (1)
- NaV1.9 (1)
- Nervenzelle (1)
- Neural circuits (1)
- Neurobiologie (1)
- Neurodegeneration (1)
- Neurofilament (1)
- Neuronal ceroid lipofuscinosis (1)
- Neurotrophin (1)
- Object recognition (1)
- Optical coherence tomography (1)
- P75 Neurotrophin receptor (1)
- PKB/Akt phosphorylation (1)
- PLEKHG5 (1)
- PTEN (1)
- Parkinson’s disease (1)
- Phosphorylation (1)
- Plasma-membrane (1)
- Pleckstrin homology containing family member 5 (Plekhg5) (1)
- Progressive motor neuronopathy (1)
- Protein kinase B (1)
- RHO (1)
- RNA splicing (1)
- RNA transport (1)
- RNA-binding proteins (1)
- ROCK (1)
- Retinal degeneration (1)
- Rictor-mTOR complex (1)
- SAP47 gene (1)
- SARS-CoV- 2 (1)
- SMARD1 (1)
- SMN (1)
- SMN granules (1)
- Sap47 (1)
- Schwann cells (1)
- Spinal Muscular-arthropy (1)
- Stat3 (1)
- Stathmin (1)
- Syap1 knockout (1)
- Syap1 localization (1)
- T-cadherin (1)
- TRP channel (1)
- Temporal-lobe epilepsy (1)
- Transcription (1)
- Transgenic mice (1)
- Vascular plasticity (1)
- Viability (1)
- YB-1 (1)
- actin messenger RNA (1)
- activation (1)
- adenocarcinoma of the lung (1)
- allosteric modulation (1)
- alpha-7 nicotinic acetylcholine receptor (1)
- amoeboid cell migration (1)
- analgesia (1)
- antibodies (1)
- antigen processing and recognition (1)
- anxiety (1)
- apoptosis (1)
- astrocytes (1)
- autism (1)
- autoantibodies (1)
- autoantibody (aAb) (1)
- autoimmune antibodies (1)
- autoimmune nodopathy (1)
- axon growth (1)
- barrier (1)
- basal ganglia (1)
- behavioral disorders (1)
- biopsies (1)
- brain (1)
- brain cancer (1)
- breast cancer (1)
- c-Jun (1)
- cadherin-13 (CDH13) (1)
- calcium channels (1)
- candidate gene (1)
- cardiology (1)
- cell death (1)
- cell staining (1)
- cells (1)
- cerebellum (1)
- cerebral blood flow (1)
- channel (1)
- choline acetyltransferase (1)
- chronic pain (1)
- ciliary neuron (1)
- ciliary-neurotrophic factor (1)
- circuits and circuit components (1)
- claudin-5 (1)
- click-chemistry (1)
- clinical neurology (1)
- cochlea (1)
- comet assay (1)
- contactin (1)
- cortico-striatal synapse (1)
- cross-sectional studies (1)
- cytosol (1)
- dSPN (1)
- dSTORM (1)
- deep brain stimulation (1)
- degeneration (1)
- demyelination (1)
- dentate gyrus (1)
- determining gene-product (1)
- direct pathway (1)
- domain (1)
- domain K\(^{+}\) channels (1)
- dominant (1)
- dorsal raphe (1)
- dorsal root ganglion (1)
- durotaxis (1)
- dynamics of ribosomal assembly (1)
- early-onset predictors (1)
- electron tomography (1)
- embryos (1)
- emotional states (1)
- energy metabolism (1)
- enrichment (1)
- epilepsy (1)
- exercise (1)
- factor prevents (1)
- fast decay (1)
- fear (1)
- fluorescence in-situ hybridization (1)
- frontotemporal dementia (1)
- fused in sarcoma (1)
- gait (1)
- gel electrophoresis (1)
- gene expression (1)
- genetic code expansion (1)
- genome wide (1)
- gephyrin (1)
- glycine receptor (GlyR) (1)
- glycine receptor autoantibodies (1)
- glycine transporter 2 (1)
- glycine uptake (1)
- glycogen phosphorylase (1)
- glycogen synthase (1)
- glycolysis (1)
- glyvine uptake (1)
- granule cells (1)
- hearing loss (1)
- hippocampal neurons (1)
- homologous recombination (1)
- human startle disease (1)
- hyaluronic acid (1)
- iPSC (induced pluripotent stem cells) (1)
- immune response (1)
- immune serum (1)
- immunocytochemical analysis (1)
- immunohistochemistry techniques (1)
- inflammatory demyelinating polyradiculoneuropathy (1)
- inflammatory neuropathy (1)
- initiation (1)
- injury (1)
- insulin (1)
- insulin-likegrowth factor I (1)
- interaction partners (1)
- interacts (1)
- interleukin 6 (1)
- interspeific backcross (1)
- intracellular domain (1)
- ion channel (1)
- ion channels in the nervous system (1)
- knockout mice (1)
- larval drosophila (1)
- library screening (1)
- ligand potencies (1)
- linalool (1)
- linalyl acetate (1)
- linkage (1)
- lithium (1)
- local protein synthesis (1)
- locomotion (1)
- loop B (1)
- loss of function (1)
- lung and intrathoracic tumors (1)
- mRNA localization (1)
- machine learning (1)
- macrophages (1)
- mechanisms (1)
- medicine (1)
- memory (1)
- mesencephalic locomotor region (1)
- metastasis (1)
- microscopy (1)
- microtubules (1)
- migraine (1)
- mild cognitive impairment (1)
- mimetic peptide (1)
- modulation (1)
- molecular mechanisms (1)
- molecular medicine (1)
- molecular neuroscience (1)
- monoclonal antibodies (1)
- motoneuron (1)
- motoneuron (MN) (1)
- motoneuron disease (1)
- motor axon (1)
- motor axons (1)
- motor control (1)
- motor learning (1)
- motor neuron degeneration (1)
- motor neurons (1)
- motor neuropathy (1)
- mouse (1)
- mouse model (1)
- movement disorders (1)
- mulitple-sclerosis patients (1)
- mushroom body (1)
- musk myasthenia gravis (1)
- mutations (1)
- myelin (1)
- nerve injury (1)
- nerve ultrasonography (1)
- nervous system (1)
- neural networks (1)
- neurodegeneration (1)
- neurodevelopment (1)
- neurofilaments (1)
- neuroinflammation (1)
- neuron migration (1)
- neuronal dendrites (1)
- neuronal differentiation (1)
- neuronal networks (1)
- neuronal primary culture (1)
- neuropathy (1)
- neuropil (1)
- neuroscience (1)
- neurotrophins (1)
- nifedipine (1)
- nociception (1)
- node of ranvier (1)
- non-small cell lung cancer (1)
- nonneuronaI cells (1)
- nuclear ribonucleoprotein-R (1)
- ontactin 1 (1)
- outer hair cell (OHC) (1)
- oxidized phospholipids (1)
- oxygenation (1)
- pain therapy (1)
- passive transfer (1)
- patch clamp recording (1)
- patch-clamp (1)
- pegylated insulin-like growth factor 1 (1)
- periperal nerve (1)
- peripheral neuropathy (1)
- phosphorylase isozymes (1)
- phosphorylation (1)
- photothrombotic stroke (1)
- postsynaptic potentials (1)
- posttranslational modifications (1)
- prefrontal cortex (1)
- presynapse (1)
- presynaptic ER dynamics (1)
- presynaptic hyperekplexia (1)
- programmed cell death (1)
- progressive encephalitis with rigidity and myoclonus (PERM) (1)
- protein coupled receptors (1)
- protein interactions (1)
- protein maturation (1)
- protein synthesis (1)
- protein transport (1)
- psychiatric disorders (1)
- quality control (1)
- radial glia (1)
- recombinant proteins (1)
- regulation (1)
- rescue (1)
- restriction fragment length polymorphism (1)
- roles (1)
- secondary lung tumors (1)
- sensory neurons (1)
- serotonin (1)
- short-term memory (1)
- side chain properties (1)
- silver staining (1)
- site (1)
- skeletal muscle (1)
- sodium channel (1)
- software (1)
- spastic (1)
- spinal cord neurons (1)
- spontaneous excitation (1)
- spontaneous mouse mutants (1)
- startle (1)
- startle reaction (1)
- stiff-person syndrome (SPS) (1)
- stroke (1)
- structural disruption (1)
- subcellular trafficking (1)
- super-resolution microscopy (SRM) (1)
- superficial peroneal nerve (1)
- sural nerve (1)
- survey (1)
- survival (1)
- switch (1)
- synapse structure (1)
- synapses (1)
- synaptic localization (1)
- synaptic transmission (1)
- synthase (1)
- systems biology (1)
- telemedicine (1)
- therapeutic antibody (1)
- thoracic diaphragm (1)
- tight junction (1)
- topotaxis (1)
- trafficking (1)
- trafficking pathways (1)
- transactivation (1)
- transport (1)
- trkB (1)
- trophic/potassium deprivation (1)
- uper-resolution array tomography (1)
- vasculitis (1)
- vector cloning (1)
- α-synuclein-specific T cells (1)
- β-actin mRNA (1)
- β8-β9 loop (1)
Institute
- Institut für Klinische Neurobiologie (101) (remove)
High-resolution ultrasonography (HRUS) is an emerging new tool in the investigation of peripheral nerves. We set out to assess the utility of HRUS performed at lower extremity nerves in peripheral neuropathies. Nerves of 26 patients with polyneuropathies of different etiologies and 26 controls were investigated using HRUS. Patients underwent clinical, laboratory, electrophysiological assessment, and a diagnostic sural nerve biopsy as part of the routine work-up. HRUS was performed at the sural, tibial, and the common, superficial, and deep peroneal nerves. The superficial peroneal nerve longitudinal diameter (LD) distinguished best between the groups: patients with immune-mediated neuropathies (n = 13, including six with histology-proven vasculitic neuropathy) had larger LD compared to patients with non-immune-mediated neuropathies (p < 0.05) and to controls (p < 0.001). Among all subgroups, patients with vasculitic neuropathy showed the largest superficial peroneal nerve LD (p < 0.001) and had a larger sural nerve cross-sectional area when compared with disease controls (p < 0.001). Enlargement of the superficial peroneal and sural nerves as detected by HRUS may be a useful additional finding in the differential diagnosis of vasculitic and other immune-mediated neuropathies.
Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling
(2016)
In neurons, microtubules form a dense array within axons, and the stability and function of this microtubule network is modulated by neurofilaments. Accumulation of neurofilaments has been observed in several forms of neurodegenerative diseases, but the mechanisms how elevated neurofilament levels destabilize axons are unknown so far. Here, we show that increased neurofilament expression in motor nerves of pmn mutant mice, a model of motoneuron disease, causes disturbed microtubule dynamics. The disease is caused by a point mutation in the tubulin-specific chaperone E (Tbce) gene, leading to an exchange of the most C-terminal amino acid tryptophan to glycine. As a consequence, the TBCE protein becomes instable which then results in destabilization of axonal microtubules and defects in axonal transport, in particular in motoneurons. Depletion of neurofilament increases the number and regrowth of microtubules in pmn mutant motoneurons and restores axon elongation. This effect is mediated by interaction of neurofilament with the stathmin complex. Accumulating neurofilaments associate with stathmin in axons of pmn mutant motoneurons. Depletion of neurofilament by Nefl knockout increases Stat3-stathmin interaction and stabilizes the microtubules in pmn mutant motoneurons. Consequently, counteracting enhanced neurofilament expression improves axonal maintenance and prolongs survival of pmn mutant mice. We propose that this mechanism could also be relevant for other neurodegenerative diseases in which neurofilament accumulation and loss of microtubules are prominent features.
Glycine receptor β–targeting autoantibodies contribute to the pathology of autoimmune diseases
(2024)
Background and Objectives
Stiff-person syndrome (SPS) and progressive encephalomyelitis with rigidity and myoclonus (PERM) are rare neurologic disorders of the CNS. Until now, exclusive GlyRα subunit–binding autoantibodies with subsequent changes in function and surface numbers were reported. GlyR autoantibodies have also been described in patients with focal epilepsy. Autoimmune reactivity against the GlyRβ subunits has not yet been shown. Autoantibodies against GlyRα1 target the large extracellular N-terminal domain. This domain shares a high degree of sequence homology with GlyRβ making it not unlikely that GlyRβ-specific autoantibody (aAb) exist and contribute to the disease pathology.
Methods
In this study, we investigated serum samples from 58 patients for aAb specifically detecting GlyRβ. Studies in microarray format, cell-based assays, and primary spinal cord neurons and spinal cord tissue immunohistochemistry were performed to determine specific GlyRβ binding and define aAb binding to distinct protein regions. Preadsorption approaches of aAbs using living cells and the purified extracellular receptor domain were further used. Finally, functional consequences for inhibitory neurotransmission upon GlyRβ aAb binding were resolved by whole-cell patch-clamp recordings.
Results
Among 58 samples investigated, cell-based assays, tissue analysis, and preadsorption approaches revealed 2 patients with high specificity for GlyRβ aAb. Quantitative protein cluster analysis demonstrated aAb binding to synaptic GlyRβ colocalized with the scaffold protein gephyrin independent of the presence of GlyRα1. At the functional level, binding of GlyRβ aAb from both patients to its target impair glycine efficacy.
Discussion
Our study establishes GlyRβ as novel target of aAb in patients with SPS/PERM. In contrast to exclusively GlyRα1-positive sera, which alter glycine potency, aAbs against GlyRβ impair receptor efficacy for the neurotransmitter glycine. Imaging and functional analyses showed that GlyRβ aAbs antagonize inhibitory neurotransmission by affecting receptor function rather than localization.
Background: Glioblastoma multiforme (GBM) and metastatic triple-negative breast cancer (TNBC) with PTEN mutations often lead to brain dissemination with poor patient outcome, thus new therapeutic targets are needed. To understand signaling, controlling the dynamics and mechanics of brain tumor cell migration, we implemented GBM and TNBC cell lines and designed 3D aligned microfibers and scaffolds mimicking brain structures. Methods: 3D microfibers and scaffolds were printed using melt electrowriting. GBM and TNBC cell lines with opposing PTEN genotypes were analyzed with RHO-ROCK-PTEN inhibitors and PTEN rescue using live-cell imaging. RNA-sequencing and qPCR of tumor cells in 3D with microfibers were performed, while scanning electron microscopy and confocal microscopy addressed cell morphology. Results: In contrast to the PTEN wildtype, GBM and TNBC cells with PTEN loss of function yielded enhanced durotaxis, topotaxis, adhesion, amoeboid migration on 3D microfibers and significant high RHOB expression. Functional studies concerning RHOB-ROCK-PTEN signaling confirmed the essential role for the above cellular processes. Conclusions: This study demonstrates a significant role of the PTEN genotype and RHOB expression for durotaxis, adhesion and migration dependent on 3D. GBM and TNBC cells with PTEN loss of function have an affinity for stiff brain structures promoting metastasis. 3D microfibers represent an important tool to model brain metastasizing tumor cells, where RHO-inhibitors could play an essential role for improved therapy.
Cell-autonomous axon growth of young motoneurons is triggered by a voltage-gated sodium channel
(2013)
Spontaneous electrical activity preceding synapse formation contributes to the precise regulation of neuronal development. Examining the origins of spontaneous activity revealed roles for neurotransmitters that depolarize neurons and activate ion channels. Recently, we identified a new molecular mechanism underlying fluctuations in spontaneous neuronal excitability. We found that embryonic motoneurons with a genetic loss of the low-threshold sodium channel Na\(_V\)1.9 show fewer fluctuations in intracellular calcium in axonal compartments and growth cones than wild-type littermates. As a consequence, axon growth of Na\(_V\)1.9-deficient motoneurons in cell culture is drastically reduced while dendritic growth and cell survival are not affected. Interestingly, Na\(_V\)1.9 function is observed under conditions that would hardly allow a ligand- or neurotransmitter-dependent depolarization. Thus, Na\(_V\)1.9 may serve as a cell-autonomous trigger for neuronal excitation. In this addendum, we discuss a model for the interplay between cell-autonomous local neuronal activity and local cytoskeleton dynamics in growth cone function.
Synapse-associated protein 1 (Syap1) is the mammalian homologue of synapse-associated protein of 47 kDa (Sap47) in Drosophila. Genetic deletion of Sap47 leads to deficiencies in short-term plasticity and associative memory processing in flies. In mice, Syap1 is prominently expressed in the nervous system, but its function is still unclear. We have generated Syap1 knockout mice and tested motor behaviour and memory. These mice are viable and fertile but display distinct deficiencies in motor behaviour. Locomotor activity specifically appears to be reduced in early phases when voluntary movement is initiated. On the rotarod, a more demanding motor test involving control by sensory feedback, Syap1-deficient mice dramatically fail to adapt to accelerated speed or to a change in rotation direction. Syap1 is highly expressed in cerebellar Purkinje cells and cerebellar nuclei. Thus, this distinct motor phenotype could be due to a so-far unknown function of Syap1 in cerebellar sensorimotor control. The observed motor defects are highly specific since other tests in the modified SHIRPA exam, as well as cognitive tasks like novel object recognition, Pavlovian fear conditioning, anxiety-like behaviour in open field dark-light transition and elevated plus maze do not appear to be affected in Syap1 knockout mice.
Background and purpose
The effects of the coronavirus disease 2019 (COVID-19) pandemic on telemedical care have not been described on a national level. Thus, we investigated the medical stroke treatment situation before, during, and after the first lockdown in Germany.
Methods
In this nationwide, multicenter study, data from 14 telemedical networks including 31 network centers and 155 spoke hospitals covering large parts of Germany were analyzed regarding patients' characteristics, stroke type/severity, and acute stroke treatment. A survey focusing on potential shortcomings of in-hospital and (telemedical) stroke care during the pandemic was conducted.
Results
Between January 2018 and June 2020, 67,033 telemedical consultations and 38,895 telemedical stroke consultations were conducted. A significant decline of telemedical (p < 0.001) and telemedical stroke consultations (p < 0.001) during the lockdown in March/April 2020 and a reciprocal increase after relaxation of COVID-19 measures in May/June 2020 were observed. Compared to 2018–2019, neither stroke patients' age (p = 0.38), gender (p = 0.44), nor severity of ischemic stroke (p = 0.32) differed in March/April 2020. Whereas the proportion of ischemic stroke patients for whom endovascular treatment (14.3% vs. 14.6%; p = 0.85) was recommended remained stable, there was a nonsignificant trend toward a lower proportion of recommendation of intravenous thrombolysis during the lockdown (19.0% vs. 22.1%; p = 0.052). Despite the majority of participating network centers treating patients with COVID-19, there were no relevant shortcomings reported regarding in-hospital stroke treatment or telemedical stroke care.
Conclusions
Telemedical stroke care in Germany was able to provide full service despite the COVID-19 pandemic, but telemedical consultations declined abruptly during the lockdown period and normalized after relaxation of COVID-19 measures in Germany.
In spinal muscular atrophy (SMA), mutations in or loss of the Survival Motor Neuron 1 (SMN1) gene reduce full-length SMN protein levels, which leads to the degeneration of a percentage of motor neurons. In mouse models of SMA, the development and maintenance of spinal motor neurons and the neuromuscular junction (NMJ) function are altered. Since nifedipine is known to be neuroprotective and increases neurotransmission in nerve terminals, we investigated its effects on cultured spinal cord motor neurons and motor nerve terminals of control and SMA mice. We found that application of nifedipine increased the frequency of spontaneous Ca\(^{2+}\) transients, growth cone size, cluster-like formations of Cav2.2 channels, and it normalized axon extension in SMA neurons in culture. At the NMJ, nifedipine significantly increased evoked and spontaneous release at low-frequency stimulation in both genotypes. High-strength stimulation revealed that nifedipine increased the size of the readily releasable pool (RRP) of vesicles in control but not SMA mice. These findings provide experimental evidence about the ability of nifedipine to prevent the appearance of developmental defects in SMA embryonic motor neurons in culture and reveal to which extent nifedipine could still increase neurotransmission at the NMJ in SMA mice under different functional demands.
CILIARY neurotrophic factor (CNTF) was originally characterized as a survival factor for chick ciliary neurons in vitro. More recently, it was shown to promote the survival of a variety of otherneuronal cell types and to affect the differentiation of E7 chick sympathetic neurons by inhibiting their proliferation and by inducing the expression of yasoactiYe intestinal peptide immunoreactiyity (VIP-IR). In cultures of dissociated sympathetic neurons from newborn rats, CNTF induces cholinergic differentiation as shown by increased levels of choline acetyltransferase (ChAT.
Ciliary neurotrophic factor (CNTF) is a potent survival molecule for a variety of embryonic neurons in culture. The developmental expression of CNTF occurs clearly after the time period of the physiological cell death of CNTF-responsive neurons. This, together with the sites of expression, excludes CNTF as a target-derived neuronal survival factor, at least in rodents. However, CNTF also participates in the induction of type 2 astrocyte differentiation in vitro. Here we demonstrate that the time course of the expression of CNTF-mRNA and protein in the rat optic nerve (as evaluated by quantitative Northern blot analysis and biological activity, respectively) is compatible with such a glial differentiation function of CNTF in vivo. We also show that the type 2 astrocyte-inducing- activity previously demonstrated in optic nerve extract can be precipitated by an antiserum against CNTF. Immunohistochemical analysis of astrocytes in vitro and in vivo demonstrates that the expression of CNTF is confined to a subpopulation of type 1 astrocytes. The olfactory bulb of adult rats has comparably high levels of CNTF to the optic nerve, and here again, CNTF-immunoreactivity is localized in a subpopulation of astrocytes. However, the postnatal expression of CNTF in the olfactory bulb occurs later than in the optic nerve. In other brain regions both CNTF-mRNA and protein levels are much lower.